Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5982545 | 0.90 | CNR2 (0.36) | CNR2HPGDACHELMNAPOLB | |
| SCHEMBL3555926 | 0.80 | HPGD (0.53) | HPGDLMNAPOLBMAPTNPSR1 | |
| SCHEMBL3547635 | 0.80 | HPGD (0.53) | HPGDLMNAPOLBMAPTNPSR1 | |
| SCHEMBL3547004 | 0.80 | HPGD (0.53) | HPGDLMNAPOLBMAPTNPSR1 | |
| SCHEMBL3548660 | 0.78 | CNR2 (0.44) | CNR2HPGDACHELMNAPOLB | |
| SCHEMBL3546909 | 0.73 | PTGS1 (0.58) | HPGDLMNAPOLBMAPTNPSR1 | |
| SCHEMBL4573986 | 0.72 | NAAA (0.43) | HPGDLMNAPOLBHTTL3MBTL1 | |
| SCHEMBL13817414 | 0.67 | CYP2C9 (0.45) | HPGDLMNAPOLBNPSR1HTT | |
| SCHEMBL3547218 | 0.65 | POLB (0.58) | HPGDACHELMNAPOLBMAPT | |
| SCHEMBL13817440 | 0.64 | HPGD (0.43) | CNR2HPGDLMNAPOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | claimed |
| CN-1902184-A | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-01-24 | — | — | CN | claimed |
| EP-1692121-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | University of Tennessee Research Foundation (US) | 2006-08-23 | — | — | EP | claimed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | claimed |
| WO-2005049591-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-06-02 | — | — | WO | claimed |
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | disclosed |
| WO-2008128179-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-16 | — | — | US | disclosed |
| EP-1926487-A2 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | University of Tennessee Research Foundation (US) | 2008-06-04 | — | — | EP | disclosed |
| WO-2008036067-A2 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-03-27 | — | — | WO | disclosed |
| US-7307093-B2 | Cancer, selectivity to prostate cancer cell lines, ovarian cancer cells | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-07-05 | — | — | US | disclosed |
| EP-1723127-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | disclosed |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | US GOVERNMENT - SECRETARY FOR THE ARMY | 2006-01-19 | — | — | US | disclosed |
| WO-2005086638-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | NAT1, AADAC, PPARG | CNR2 1063/4885HPGD 371/4885ACHE 2626/4885 |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | MKI67, MCL1, API5 | CNR2 3991/4885HPGD 242/4885ACHE 3570/4885 |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | NAT1, AADAC, PPARG | CNR2 1063/4885HPGD 371/4885ACHE 2626/4885 |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | CNR2 2863/4885HPGD 1254/4885ACHE 4110/4885 |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | CNR2 2732/4885HPGD 969/4885ACHE 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.